個別化がんワクチンの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2692)
◆英語タイトル:Global Personalized Cancer Vaccines Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2692
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、個別化がんワクチンの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(肺がん、乳がん、結腸直腸がん、白血病、前立腺がん、子宮頸がん、神経膠芽細胞腫、その他)、用途別市場規模(病院、在宅医療、専門クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・個別化がんワクチンの市場動向
・企業の競争状況、市場シェア
・個別化がんワクチンの種類別市場規模(肺がん、乳がん、結腸直腸がん、白血病、前立腺がん、子宮頸がん、神経膠芽細胞腫、その他)
・個別化がんワクチンの用途別市場規模(病院、在宅医療、専門クリニック、その他)
・個別化がんワクチンの北米市場規模2016-2027(アメリカ、カナダ)
・個別化がんワクチンの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・個別化がんワクチンのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・個別化がんワクチンの中南米市場規模2016-2027(メキシコ、ブラジル)
・個別化がんワクチンの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Advaxis Inc、Personalis、Hoffmann-La Roche Ltd、BioNtech、Celldex、CureVac AG、Genetech、Genocea、Gritstone Oncology、ISA Pharmaceuticals、Merck、Moderna Therapeutics)
・結論
【レポートの概要】

Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patient’s particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells and inhibit the growth of tumors cells.

Market Analysis and Insights: Global Personalized Cancer Vaccines Market
The global Personalized Cancer Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Cancer Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Cancer Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Cancer Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Cancer Vaccines market.

Global Personalized Cancer Vaccines Scope and Market Size
Personalized Cancer Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Cancer Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
By Cancer Type
Lung Cancer
Breast Cancer
Colorectal Cancer
Leukemia
Prostate Cancer
Cervical Cancer
Glioblastoma
Others
By Mechanism of Action Type
Tumor-associated antigens (TAAs)
Tumor-specific antigens (TSAs)
Somatic Mutations in Cancer Pharmacogenomics
Pharmacogenomics towards Genomic Polymorphism

Segment by Application
Hospitals
Homecare
Specialty Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Advaxis Inc
Personalis
Hoffmann-La Roche Ltd
BioNtech
Celldex
CureVac AG
Genetech
Genocea
Gritstone Oncology
ISA Pharmaceuticals
Merck
Moderna Therapeutics

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Cancer Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Lung Cancer
1.2.3 Breast Cancer
1.2.4 Colorectal Cancer
1.2.5 Leukemia
1.2.6 Prostate Cancer
1.2.7 Cervical Cancer
1.2.8 Glioblastoma
1.2.9 Others
1.3 Market by Application
1.3.1 Global Personalized Cancer Vaccines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Personalized Cancer Vaccines Market Perspective (2016-2027)
2.2 Personalized Cancer Vaccines Growth Trends by Regions
2.2.1 Personalized Cancer Vaccines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Personalized Cancer Vaccines Historic Market Share by Regions (2016-2021)
2.2.3 Personalized Cancer Vaccines Forecasted Market Size by Regions (2022-2027)
2.3 Personalized Cancer Vaccines Industry Dynamic
2.3.1 Personalized Cancer Vaccines Market Trends
2.3.2 Personalized Cancer Vaccines Market Drivers
2.3.3 Personalized Cancer Vaccines Market Challenges
2.3.4 Personalized Cancer Vaccines Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Personalized Cancer Vaccines Players by Revenue
3.1.1 Global Top Personalized Cancer Vaccines Players by Revenue (2016-2021)
3.1.2 Global Personalized Cancer Vaccines Revenue Market Share by Players (2016-2021)
3.2 Global Personalized Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Personalized Cancer Vaccines Revenue
3.4 Global Personalized Cancer Vaccines Market Concentration Ratio
3.4.1 Global Personalized Cancer Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Cancer Vaccines Revenue in 2020
3.5 Personalized Cancer Vaccines Key Players Head office and Area Served
3.6 Key Players Personalized Cancer Vaccines Product Solution and Service
3.7 Date of Enter into Personalized Cancer Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Personalized Cancer Vaccines Breakdown Data by Type
4.1 Global Personalized Cancer Vaccines Historic Market Size by Type (2016-2021)
4.2 Global Personalized Cancer Vaccines Forecasted Market Size by Type (2022-2027)

5 Personalized Cancer Vaccines Breakdown Data by Application
5.1 Global Personalized Cancer Vaccines Historic Market Size by Application (2016-2021)
5.2 Global Personalized Cancer Vaccines Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Personalized Cancer Vaccines Market Size (2016-2027)
6.2 North America Personalized Cancer Vaccines Market Size by Type
6.2.1 North America Personalized Cancer Vaccines Market Size by Type (2016-2021)
6.2.2 North America Personalized Cancer Vaccines Market Size by Type (2022-2027)
6.2.3 North America Personalized Cancer Vaccines Market Size by Type (2016-2027)
6.3 North America Personalized Cancer Vaccines Market Size by Application
6.3.1 North America Personalized Cancer Vaccines Market Size by Application (2016-2021)
6.3.2 North America Personalized Cancer Vaccines Market Size by Application (2022-2027)
6.3.3 North America Personalized Cancer Vaccines Market Size by Application (2016-2027)
6.4 North America Personalized Cancer Vaccines Market Size by Country
6.4.1 North America Personalized Cancer Vaccines Market Size by Country (2016-2021)
6.4.2 North America Personalized Cancer Vaccines Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Personalized Cancer Vaccines Market Size (2016-2027)
7.2 Europe Personalized Cancer Vaccines Market Size by Type
7.2.1 Europe Personalized Cancer Vaccines Market Size by Type (2016-2021)
7.2.2 Europe Personalized Cancer Vaccines Market Size by Type (2022-2027)
7.2.3 Europe Personalized Cancer Vaccines Market Size by Type (2016-2027)
7.3 Europe Personalized Cancer Vaccines Market Size by Application
7.3.1 Europe Personalized Cancer Vaccines Market Size by Application (2016-2021)
7.3.2 Europe Personalized Cancer Vaccines Market Size by Application (2022-2027)
7.3.3 Europe Personalized Cancer Vaccines Market Size by Application (2016-2027)
7.4 Europe Personalized Cancer Vaccines Market Size by Country
7.4.1 Europe Personalized Cancer Vaccines Market Size by Country (2016-2021)
7.4.2 Europe Personalized Cancer Vaccines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Personalized Cancer Vaccines Market Size (2016-2027)
8.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type
8.2.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Type (2016-2027)
8.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application
8.3.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Personalized Cancer Vaccines Market Size by Application (2016-2027)
8.4 Asia-Pacific Personalized Cancer Vaccines Market Size by Region
8.4.1 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Personalized Cancer Vaccines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Personalized Cancer Vaccines Market Size (2016-2027)
9.2 Latin America Personalized Cancer Vaccines Market Size by Type
9.2.1 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2021)
9.2.2 Latin America Personalized Cancer Vaccines Market Size by Type (2022-2027)
9.2.3 Latin America Personalized Cancer Vaccines Market Size by Type (2016-2027)
9.3 Latin America Personalized Cancer Vaccines Market Size by Application
9.3.1 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2021)
9.3.2 Latin America Personalized Cancer Vaccines Market Size by Application (2022-2027)
9.3.3 Latin America Personalized Cancer Vaccines Market Size by Application (2016-2027)
9.4 Latin America Personalized Cancer Vaccines Market Size by Country
9.4.1 Latin America Personalized Cancer Vaccines Market Size by Country (2016-2021)
9.4.2 Latin America Personalized Cancer Vaccines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Personalized Cancer Vaccines Market Size (2016-2027)
10.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type
10.2.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Type (2016-2027)
10.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application
10.3.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Personalized Cancer Vaccines Market Size by Application (2016-2027)
10.4 Middle East & Africa Personalized Cancer Vaccines Market Size by Country
10.4.1 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Personalized Cancer Vaccines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Advaxis Inc
11.1.1 Advaxis Inc Company Details
11.1.2 Advaxis Inc Business Overview
11.1.3 Advaxis Inc Personalized Cancer Vaccines Introduction
11.1.4 Advaxis Inc Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.1.5 Advaxis Inc Recent Development
11.2 Personalis
11.2.1 Personalis Company Details
11.2.2 Personalis Business Overview
11.2.3 Personalis Personalized Cancer Vaccines Introduction
11.2.4 Personalis Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.2.5 Personalis Recent Development
11.3 Hoffmann-La Roche Ltd
11.3.1 Hoffmann-La Roche Ltd Company Details
11.3.2 Hoffmann-La Roche Ltd Business Overview
11.3.3 Hoffmann-La Roche Ltd Personalized Cancer Vaccines Introduction
11.3.4 Hoffmann-La Roche Ltd Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.3.5 Hoffmann-La Roche Ltd Recent Development
11.4 BioNtech
11.4.1 BioNtech Company Details
11.4.2 BioNtech Business Overview
11.4.3 BioNtech Personalized Cancer Vaccines Introduction
11.4.4 BioNtech Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.4.5 BioNtech Recent Development
11.5 Celldex
11.5.1 Celldex Company Details
11.5.2 Celldex Business Overview
11.5.3 Celldex Personalized Cancer Vaccines Introduction
11.5.4 Celldex Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.5.5 Celldex Recent Development
11.6 CureVac AG
11.6.1 CureVac AG Company Details
11.6.2 CureVac AG Business Overview
11.6.3 CureVac AG Personalized Cancer Vaccines Introduction
11.6.4 CureVac AG Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.6.5 CureVac AG Recent Development
11.7 Genetech
11.7.1 Genetech Company Details
11.7.2 Genetech Business Overview
11.7.3 Genetech Personalized Cancer Vaccines Introduction
11.7.4 Genetech Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.7.5 Genetech Recent Development
11.8 Genocea
11.8.1 Genocea Company Details
11.8.2 Genocea Business Overview
11.8.3 Genocea Personalized Cancer Vaccines Introduction
11.8.4 Genocea Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.8.5 Genocea Recent Development
11.9 Gritstone Oncology
11.9.1 Gritstone Oncology Company Details
11.9.2 Gritstone Oncology Business Overview
11.9.3 Gritstone Oncology Personalized Cancer Vaccines Introduction
11.9.4 Gritstone Oncology Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.9.5 Gritstone Oncology Recent Development
11.10 ISA Pharmaceuticals
11.10.1 ISA Pharmaceuticals Company Details
11.10.2 ISA Pharmaceuticals Business Overview
11.10.3 ISA Pharmaceuticals Personalized Cancer Vaccines Introduction
11.10.4 ISA Pharmaceuticals Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.10.5 ISA Pharmaceuticals Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Personalized Cancer Vaccines Introduction
11.11.4 Merck Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.11.5 Merck Recent Development
11.12 Moderna Therapeutics
11.12.1 Moderna Therapeutics Company Details
11.12.2 Moderna Therapeutics Business Overview
11.12.3 Moderna Therapeutics Personalized Cancer Vaccines Introduction
11.12.4 Moderna Therapeutics Revenue in Personalized Cancer Vaccines Business (2016-2021)
11.12.5 Moderna Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 個別化がんワクチンの世界市場規模・現状・予測2021年-2027年(Global Personalized Cancer Vaccines Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。